For people trying to figure out how to deal with their prostate cancer, there is a new piece of evidence that will add to the debate.
For one in 10 men with prostate cancer, their disease has become locally advanced and spread beyond the prostate but not metastasized. While men whose cancer is confined to the prostate have a survival rate that approaches 100%, the survival rate drops down significantly for men with locally advanced. Almost 10-40% of such men will die within 5 years of diagnosis. So these men need treatment. Unfortunately, there is no agreement on which is the most effective treatment. Choices include:
- Surgery
- Radiotherapy
- Hormone therapy
Researchers looked at the treatment for nearly 14,000 men whose cancer had spread beyond the prostate. After nearly 15 years, they found:
- There was a 15% survival advantage among the men treated with surgery followed by radiation compared to those who got radiation and hormone treatment.
- There were higher rates of erectile dysfunction and much higher rates of incontinence in the surgery/radiation group.
- 50% of the men received only one treatment – not two as recommended.
So is that 15% survival advantage important? Dr. David Crawford, head of urologic oncology at the University of Colorado Denver, doesn’t think the differences were very big in the various treatments. “Most patients survived in excess of 10 years,” he said.
As for whether this study should have an impact on treatment decisions for patients, Dr. Stanley Liauw, a Radiation oncologist from the University of Chicago Medicine said “for select patients, it is possible that an approach of surgery followed by radiation may lead to more favorable oncologic outcomes, but it would not be appropriate to promote this as a general rule based on this study alone.” Liauw also noted the study looked at data from 1992 and is “unlikely to represent practice patterns today.” For example brachytherapy, placing radioactive seeds into the prostate, was not included in the study. Liauw said, “a recent randomized study demonstrates that this radiation modality results in a more favorable outcome than external beam radiation.”
There are studies currently underway trying to determine what is the best treatment for patients with this kind of prostate cancer. But the lack of any clear-cut “best therapy” underscores the importance of patients having a thorough discussion with their doctor about the benefits and the risks of the different treatments.
Learn more about SurvivorNet's rigorous medical review process.